These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4015850)

  • 21. Studies on acute tolerance to ethanol in the abstinence period after long-term barbital treatment in the rat.
    Wahlström G
    Acta Pharmacol Toxicol (Copenh); 1979 Aug; 45(2):152-60. PubMed ID: 573957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disposition of hexobarbital in the rat. Estimation of "first-pass" elimination and influence of ether anesthesia.
    Vermeulen NP; Danhof M; Setiawan I; Breimer DD
    J Pharmacol Exp Ther; 1983 Jul; 226(1):201-5. PubMed ID: 6864540
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Mechanisms of hexobarbital anesthesia potentiation by hydrocortisone].
    Tancheva L; Stoĭchev Ts
    Eksp Med Morfol; 1979; 18(3):144-50. PubMed ID: 499039
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of the rate of hepatic portal vein infusion on hexobarbital pharmacokinetics in the rat.
    Joeres RP; Vermeulen NP; Breimer DD
    Pharmacology; 1988; 36(3):210-6. PubMed ID: 3368506
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of major effects of ethanol, chlorpromazine, hexobarbital and haloperidol on brain gangliosides.
    Miller-Podraza H; Rakowska M; Skarzyńska E
    Acta Biochim Pol; 1990; 37(2):243-50. PubMed ID: 2072982
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Maturation-related changes in tolerance development to hexobarbital after short term treatment with diazepam in the rat.
    Korkmaz S; Carlsson S; Wahlström G
    Brain Res; 1993 Jan; 600(2):345-8. PubMed ID: 8435757
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of chronic ethanol administration in the rat: relative dependency on dietary lipids--III. In vivo tolerance to hexobarbital.
    Hétu C; Joly JG
    Biochem Pharmacol; 1979 Mar; 28(6):841-7. PubMed ID: 454481
    [No Abstract]   [Full Text] [Related]  

  • 28. Uptake and distribution of boron in rats: interaction with ethanol and hexobarbital in the brain.
    Magour S; Schramel P; Ovcar J; Mäser H
    Arch Environ Contam Toxicol; 1982 Sep; 11(5):521-5. PubMed ID: 7149769
    [No Abstract]   [Full Text] [Related]  

  • 29. Pregnenolone sulphate and pregnenolone do not interact with 5 beta-pregnanolone- and hexobarbitone-induced anaesthesia in the rat.
    Wang MD; Wahlström G; Bäckström T
    Br J Anaesth; 1997 Mar; 78(3):328-31. PubMed ID: 9135318
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction of the competitive AMPA receptor antagonist NBQX with hexobarbital.
    Dall V; Orntoft U; Schmidt A; Nordholm L
    Pharmacol Biochem Behav; 1993 Sep; 46(1):73-6. PubMed ID: 8255925
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of castration and testosterone treatment on the hexobarbital sensitivity in male rats.
    Bolander HG; Kourtopoulos H
    Life Sci; 1985 Mar; 36(10):907-12. PubMed ID: 3974400
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased penetration of barbital through the bloodbrain barrier in the rat after pretreatment with probenecid.
    Wahlström G
    Acta Pharmacol Toxicol (Copenh); 1978 Oct; 43(4):260-5. PubMed ID: 716942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction between flumazenil and the anesthetic effects of hexobarbital in the rat.
    Korkmaz S; Ljungblad E; Wahlström G
    Brain Res; 1995 Apr; 676(2):371-7. PubMed ID: 7614008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of chronic felbamate administration on anticonvulsant activity and hepatic drug-metabolizing enzymes in mice and rats.
    Swinyard EA; Woodhead JH; Franklin MR; Sofia RD; Kupferberg HJ
    Epilepsia; 1987; 28(3):295-300. PubMed ID: 3107974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction between probenecid and two lipid-soluble barbiturates in the rat.
    Bolander HG; Wahlström G
    Neuropharmacology; 1984 Aug; 23(8):977-81. PubMed ID: 6483121
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of atropine on the tolerance and the convulsions seen after withdrawal from forced barbital drinking in the rat.
    Wahlström G
    Psychopharmacology (Berl); 1978 Oct; 59(2):123-8. PubMed ID: 103112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmocokinetics of hexobarbital in man after intravenous infusion.
    Breimer DD; Honhoff C; Zilly W; Richter E; van Rossum JM
    J Pharmacokinet Biopharm; 1975 Feb; 3(1):1-11. PubMed ID: 1127574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Experimental intravenous novocaine hexobarbital anesthesia with morphine premedication].
    Gasparian SA; Korolev VS
    Eksp Khir Anesteziol; 1966; 11(4):87-8. PubMed ID: 5989365
    [No Abstract]   [Full Text] [Related]  

  • 39. [True hexobarbital tolerance].
    Stumpf C; Chiari I
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1965 Jul; 251(3):275-87. PubMed ID: 4222703
    [No Abstract]   [Full Text] [Related]  

  • 40. The EEG burst suppression threshold test for the determination of CNS sensitivity to intravenous anesthetics in rats.
    Korkmaz S; Wahlström G
    Brain Res Brain Res Protoc; 1997 Oct; 1(4):378-84. PubMed ID: 9384819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.